Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Dahl%2C+Christina%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Dahl%2C+Christina%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2018
Mark Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON) : A multicentre, open-label, single-arm, phase 2 trial
Jerkeman, Mats ^LU ; Eskelund, Christian Winther ; Hutchings, Martin ; Räty, Riikka ; Wader, Karin Fahl ; Laurell, Anna ^LU ; Toldbod, Helle ; Pedersen, Lone Bredo ; Niemann, Carsten Utoft and Dahl, Christina , et al. (2018) In The Lancet Haematology 5(3). p.109-116
- Contribution to journal › Article
2017
Mark TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy
Eskelund, Christian W. ; Dahl, Christina ; Hansen, Jakob W. ; Westman, Maj ; Kolstad, Arne ; Pedersen, Lone B. ; Montano-Almendras, Carmen P. ; Husby, Simon ; Freiburghaus, Catja ^LU and Ek, Sara ^LU , et al. (2017) In Blood 130(17). p.1903-1910
- Contribution to journal › Article
2013
Mark Mutual Exclusivity Analysis of Genetic and Epigenetic Drivers in Melanoma Identifies a Link Between p14(ARF) and RAR beta Signaling
Dahl, Christina ; Christensen, Claus ; Jönsson, Göran B ^LU ; Lorentzen, Anders ; Skjodt, Mette Louise ; Borg, Åke ^LU ; Pawelec, Graham and Guldberg, Per (2013) In Molecular Cancer Research 11(10). p.1166-1178
- Contribution to journal › Article

your query:: Remove author: Dahl, Christina